Citi: Only one insurance stock worth buying amid the Royal Commission chaos

It's hard to build a case to buy insurance stocks when the Royal Commission is uncovering dodgy practices that will haunt the sector for a long time. But there may be an exception.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's hard to build a case to buy insurance stocks when the Royal Commission is uncovering dodgy practices that will haunt the industry for a long time and I am expecting further underperformance from the sector.

As it stands, the share prices of our major general insurers such as Insurance Australia Group Ltd (ASX: IAG) and Suncorp Group Ltd (ASX: SUN) are down close to 1% in afternoon trade when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) is up 0.6%.

The losses arn't as bad as smaller insurer Clearview Wealth Ltd (ASX: CVW) with its 5% crash as its chief executive admitted to the Royal Commission that the company breached the law 300,000 times.

There is one in the sector that is bucking the trend though. It's QBE Insurance Group Ltd (ASX: QBE) with the stock trading at break-even at the time of writing, and this is the only general insurer that Citigroup thinks is worth buying even though the broker thinks general insurers are the most attractive part of the sector at the moment.

I couldn't agree more. QBE is the only insurance stock I like and I think it will be least impacted by the Royal Commission thanks to its highly diversified business that spans several countries.

The irony is that QBE is regarded as a dog due to its long history of disappointing shareholders. But last month's results showed that every dog has its day.

"We believe QBE's 1H18 result is its first step on the road to redemption. We saw enough evidence in it to suggest the stock can move further along this road although, in our view, the next leg of share price performance may be harder than the gains from a result that, for once, failed to disappoint," said Citigroup.

"We believe the stock currently offers the best value in the sector and, while the risk profile is elevated, we remain optimistic of further progress with potential for meaningful medium-term upside if our forecasts are delivered."

I also believe that QBE is best leveraged to rising US government bond yields and the rising US dollar than its peers as it has a significant exposure to that market.

The rising US Treasury yields may be the thing that keeps QBE's share price on the uptrend. Experts have noted that it takes a year or two before insurers like QBE start to see the benefit from higher yields on their bottom line.

We can only hope that management doesn't do anything to damage the investor goodwill the company is starting to receive.

But QBE isn't the only large cap stock that should be on your radar. The experts at the Motley Fool have picked three of their best blue-chip stock ideas for FY19, and you can find out what these stocks are for free by following the link below.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Insurance Australia Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

A young female investor with brown curly hair and wearing a yellow top and glasses sits at her desk using her calculator to work out how much her ASX dividend shares will pay this year
Cheap Shares

Why I would invest $10,000 in these cheap ASX shares

Sharp share price falls can create opportunity when business quality remains intact.

Read more »

Scientist with headache, stress and fatigue with woman, overworked with overtime for science breakthrough. Medical research, scientific innovation and senior female, burnout and migraine in lab.
Cheap Shares

Are CSL shares still a bargain at $177?

After a sharp sell-off, expectations have reset. The key question is whether the business has truly changed.

Read more »

A kid stretches up to reach the top of the ruler drawn on the wall behind.
Cheap Shares

2 undervalued ASX shares worth buying today

These quality ASX 200 stocks could offer 50-75% upside.

Read more »

A man thinks very carefully about his money and investments.
Cheap Shares

The 3 best undervalued ASX shares I'd pick up in January

3 high-quality ASX shares look undervalued as short-term concerns create potential long-term opportunities.

Read more »

A group of business people pump the air and cheer.
Cheap Shares

Still under $30, these wealth-builders may not stay cheap for long

Want to buy quality when it is cheap? Check out these options.

Read more »

Two people jump and high five above a city skyline.
Cheap Shares

2 beaten-down ASX shares to consider before they recover

These shares were sold off in 2025. Could they rebound in 2026?

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Cheap Shares

2 ASX shares these experts rate as a buy right now

Experts think these stocks are underrated buys.

Read more »

Woman dining at a table with oversized fork and knife in the hospitality industry.
Cheap Shares

Why I think this ASX small-cap stock is a bargain at $2.55

This stock looks eggcellent value to me.

Read more »